These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 32037154)
1. Acute Kidney Injury During Treatment with Intravenous Acyclovir for Suspected or Confirmed Neonatal Herpes Simplex Virus Infection. Downes KJ; Boge CLK; Baro E; Wharton GT; Liston KM; Haltzman BL; Emerson HM; Doe E; Fulchiero R; Tran V; Yen L; Lieu P; Van Driest SL; Grisso AG; Aka IT; Hale J; Gillon J; Pingel JS; Coffin SE; McMahon AW J Pediatr; 2020 Apr; 219():126-132.e2. PubMed ID: 32037154 [TBL] [Abstract][Full Text] [Related]
2. Safety of High-dose Acyclovir in Infants With Suspected and Confirmed Neonatal Herpes Simplex Virus Infections. Ericson JE; Gostelow M; Autmizguine J; Hornik CP; Clark RH; Benjamin DK; Smith PB; Pediatr Infect Dis J; 2017 Apr; 36(4):369-373. PubMed ID: 27977557 [TBL] [Abstract][Full Text] [Related]
3. Acute kidney injury following intravenous acyclovir in children. Sandery BJ; Erlich JH; Kennedy SE Arch Dis Child; 2020 Dec; 105(12):1215-1219. PubMed ID: 32404442 [TBL] [Abstract][Full Text] [Related]
4. Risk of acute kidney injury from oral acyclovir: a population-based study. Lam NN; Weir MA; Yao Z; Blake PG; Beyea MM; Gomes T; Gandhi S; Mamdani M; Wald R; Parikh CR; Hackam DG; Garg AX Am J Kidney Dis; 2013 May; 61(5):723-9. PubMed ID: 23312723 [TBL] [Abstract][Full Text] [Related]
5. Factors associated with acyclovir nephrotoxicity in children: data from 472 pediatric patients from the last 10 years. Yalçınkaya R; Öz FN; Kaman A; Aydın Teke T; Yaşar Durmuş S; Çelikkaya E; Tanır G Eur J Pediatr; 2021 Aug; 180(8):2521-2527. PubMed ID: 33956193 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic and therapeutic management for suspected neonatal herpes simplex virus infection. Wolfert SI; de Jong EP; Vossen AC; Zwaveling J; Te Pas AB; Walther FJ; Lopriore E J Clin Virol; 2011 May; 51(1):8-11. PubMed ID: 21388869 [TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Kimberlin DW; Lin CY; Jacobs RF; Powell DA; Corey L; Gruber WC; Rathore M; Bradley JS; Diaz PS; Kumar M; Arvin AM; Gutierrez K; Shelton M; Weiner LB; Sleasman JW; de Sierra TM; Weller S; Soong SJ; Kiell J; Lakeman FD; Whitley RJ; Pediatrics; 2001 Aug; 108(2):230-8. PubMed ID: 11483782 [TBL] [Abstract][Full Text] [Related]
9. The incidence, risk factors, and clinical outcomes of acute kidney injury (staged using the RIFLE classification) associated with intravenous acyclovir administration. Lee EJ; Jang HN; Cho HS; Bae E; Lee TW; Chang SH; Park DJ Ren Fail; 2018 Nov; 40(1):687-692. PubMed ID: 30741619 [TBL] [Abstract][Full Text] [Related]
10. Intravenous acyclovir and renal dysfunction in children: a matched case control study. Rao S; Abzug MJ; Carosone-Link P; Peterson T; Child J; Siparksy G; Soranno D; Cadnapaphornchai MA; Simões EA J Pediatr; 2015 Jun; 166(6):1462-8.e1-4. PubMed ID: 25708691 [TBL] [Abstract][Full Text] [Related]
11. Exposure-safety relationship for acyclovir in the treatment of neonatal herpes simplex virus disease. Ericson JE; Benjamin DK; Boakye-Agyeman F; Balevic SJ; Cotten CM; Adler-Shohet F; Laughon M; Poindexter B; Harper B; Payne EH; Kaneshige K; Smith PB; Early Hum Dev; 2022 Jul; 170():105616. PubMed ID: 35763957 [TBL] [Abstract][Full Text] [Related]
12. Neonatal Herpes Simplex Virus: The Long Road to Improved Outcomes. McPherson CC Neonatal Netw; 2020 Mar; 39(2):92-98. PubMed ID: 32317339 [TBL] [Abstract][Full Text] [Related]